Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Keybanc Maintains Overweight on Alkami Technology, Raises Price Target to $18

Keybanc Maintains Overweight on Alkami Technology, Raises Price Target to $18

Keybanc analyst Josh Beck maintains Alkami Technology (NASDAQ:ALKT) with a Overweight and raises the price target from $16 to $18.

January 20, 2023

1 minute read

Keybanc analyst Josh Beck maintains Alkami Technology (NASDAQ:ALKT) with a Overweight and raises the price target from $16 to $18.

6 Analysts Have This to Say About Arvinas

June 9, 8:08 AM

Arvinas (NASDAQ:ARVN) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish…

February 13, 6:48 AM

Despite the recent rout in the Adani Group of companies’ stock after the US-based Hindenburg Research report, the…

November 3, 12:57 PM

Cummins Inc (NYSE:CMI) reported third-quarter sales growth of 23% year-over-year to $7.33 billion, beating the consensus of $6.80 billion. Excluding…

November 15, 7:21 AM

HC Wainwright & Co. analyst Andrew Fein maintains Syros Pharmaceuticals (NASDAQ:SYRS) with a Buy and raises the price target from $6 to $20.